EU-OPENSCREEN: A Future Pan-European Research Infrastructure for Chemical Biology; Sharing Samples, Expertise and Knowledge for the Discovery of Bioactive Small Molecules
Dr. Ronald Frank, Head of Research Group, Chemical Systems Biology, Leibniz- Institut fur Molekulare Pharmakologie (FMP), speaks to Pharma IQ about the EU-OPENSCREEN project initiative, funding and plans. EU-OPENSCREEN, the European Infrastructure of Open Screening Platforms for Chemical Biology, integrates high-throughput screening platforms, chemical libraries, chemical resources for hit discovery and optimisation, bio- and cheminformatics support, and a database containing screening results, assay protocols, and chemical information.
This interview was conducted at IQPC's 8th Compound Management & Integrity event in May 2011.
Have Your Say
Rate this feature and give us your feedback in the comments section below